Diabetes
Risk Assessment of Diabetes Mellitus During and After Pregnancy in Women With Prolactinomas | The Journal of Clinical Endocrinology & Metabolism
Get help with access
Institutional access
Access to content on Oxford Academic is often provided through institutional subscripti...
Latino-focused Diabetes prevention program heads to Georgia
At the start of 2024, the 1 million Hispanic people living in Georgia will be invited to join in a new diabetes prevention program thanks to a gran...
Reducing diabetes among the African American community
LOS ANGELES — November is Diabetes Awarness Month, highlighting the chronic condition affecting around 38 million Americans. People of color face u...
Uptake of diabetes follow-up checks by minority community groups: a rapid review of the evidence for the CYMELL study
Background:
Type 2 diabetes is a public health priority for the UK. A growing body of evidence has indicated ethnic and socioeconomi...
User-Centered Design of a Diabetes Self-Management Tool for Underserved Populations
Background:
User-centered design (UCD) or user experience design (UXD) methods have gained recent popularity for the design of mobil...
Exploring the Relationship Between Medication Adherence and Diabetes Disparities among Hispanic Patients in a Large Health System
Background:
Sub-optimal HbA1c control is a driver of disparities in diabetes outcomes among Hispanic patients. Differences in medica...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
